Publication:
The cysteine-rich domain of TET2 binds preferentially to mono- and dimethylated histone H3K36

Thumbnail Image

Date

2017

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Oxford University Press
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Yamagata, Kazuyuki, and Akira Kobayashi. 2017. “The cysteine-rich domain of TET2 binds preferentially to mono- and dimethylated histone H3K36.” Journal of Biochemistry 161 (4): 327-330. doi:10.1093/jb/mvx004. http://dx.doi.org/10.1093/jb/mvx004.

Research Data

Abstract

Missense mutations in Ten-eleven translocation 2 (TET2) gene are frequently found in leukaemia patients. Although mutations span the entire coding region, they tend to cluster in the C-terminal enzymatic domain and a cysteine-rich (CR) domain of unknown function. Herein, we found the CR domain binds chromatin preferentially at the histone H3 tail by recognising H3 lysine 36 mono- and dimethylation (H3K36me1/2). Importantly, missense mutations in the CR domain perturbed TET2 recruitment to the target locus and its enzymatic activities. Our findings identify a novel H3K36me recognition domain and uncover a critical link between histone modification and DNA hydroxylation in leukaemogenesis.

Description

Keywords

epigenetics, TET2, leukaemia, histone H3K36 methylation, histones < chromosomes

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories